<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25784" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neurofibroma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Messersmith</surname>
            <given-names>Lynn</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krauland</surname>
            <given-names>Kevin</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lynn Messersmith declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kevin Krauland declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25784.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neurofibromas are the most common peripheral nerve sheath tumor and are often found either by patients or during routine skin exams. These lesions appear as soft, skin-colored papules or small subcutaneous nodules. There are three main types of neurofibromas: localized, diffuse, and plexiform. The majority of neurofibromas are sporadically-occurring and localized and have an extremely low risk of malignant transformation. However, the plexiform type is pathognomonic for neurofibromatosis type 1 and carries an increased risk of malignant transformation. This activity reviews the evaluation and management of neurofibromas and highlights the role of the interprofessional team in managing affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the appearance of a neurofibroma.</p></list-item><list-item><p>Explain how to counsel a patient with multiple cutaneous neurofibromas or a plexiform neurofibroma.</p></list-item><list-item><p>Identify management considerations for patients presenting with neurofibromas.</p></list-item><list-item><p>Explain the importance of collaboration and communication amongst the interprofessional team to improve outcomes for patients affected by neurofibromas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25784&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25784">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25784.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neurofibromas are the most prevalent benign peripheral nerve sheath tumor. Often appearing as a soft, skin-colored papule or small subcutaneous nodule, they arise from endoneurium and the connective tissues of peripheral nerve sheaths. Neurofibromas are comprised of Schwann cells, fibroblasts, perineural cells, and mast cells in a variably myxoid background.<xref ref-type="bibr" rid="article-25784.r1">[1]</xref>&#x000a0;A mutation in the NF1 gene causes neurofibromas.&#x000a0;There are three main types of neurofibromas: localized (most common), diffuse, and plexiform. Although the majority of neurofibromas occur sporadically and have an extremely low risk of malignant transformation, the plexiform type is pathognomonic for neurofibromatosis type 1 (NF 1). It carries an increased risk of malignant transformation.<xref ref-type="bibr" rid="article-25784.r2">[2]</xref>&#x000a0;The complete&#x000a0;excision of the lesion is curative.</p>
      </sec>
      <sec id="article-25784.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Approximately 90% of cases occur sporadically, while the remaining cases are associated with neurofibromatosis type 1 or 2.<xref ref-type="bibr" rid="article-25784.r3">[3]</xref><xref ref-type="bibr" rid="article-25784.r2">[2]</xref></p>
      </sec>
      <sec id="article-25784.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Neurofibromas are the most common tumor of the peripheral nerve sheath, affecting men and women equally, without racial or ethnic predilection. Age of onset is highly variable; however, localized lesions most commonly occur in adults aged 20 to 40 years. The diffuse and plexiform types occur more frequently in children, with the plexiform type rarely occurring after age 5.<xref ref-type="bibr" rid="article-25784.r4">[4]</xref></p>
      </sec>
      <sec id="article-25784.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In both sporadic and syndromic cases, neurofibromas are a result of a deletion in the NF1 gene. In sporadic cases, only the lesional cells carry the NF1 mutation. In syndromic cases, neurofibromas are the result of a germline mutation in NF1, encoding the tumor suppressor protein&#x000a0;neurofibromin, on chromosome 17q11.2.<xref ref-type="bibr" rid="article-25784.r5">[5]</xref><xref ref-type="bibr" rid="article-25784.r6">[6]</xref></p>
      </sec>
      <sec id="article-25784.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Macroscopic: Often an unencapsulated, well-circumscribed, grey-tan firm mass. Typically ovoid or fusiform, with a pale gelatinous cut surface. Usually, no areas of degeneration, necrosis, or hemorrhage are grossly identified. There may be transected nerve fibers attached to the mass forming portion of the lesion.<xref ref-type="bibr" rid="article-25784.r7">[7]</xref>&#x000a0;The plexiform type is often large, with multiple&#x000a0;tortuous nerve fascicles, grossly described as a "bag of worms."</p>
        <p><bold>Microscopic Exam Histologic Features</bold>
<xref ref-type="bibr" rid="article-25784.r8">[8]</xref><xref ref-type="bibr" rid="article-25784.r7">[7]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Loose and haphazard spindled cells with poorly defined cell borders</p>
          </list-item>
          <list-item>
            <p>Background of myxoid to pale pink collagenous matrix
<list list-type="bullet"><list-item><p>Coarse collagen bundles are present and often described as &#x0201c;shredded carrots.&#x0201d;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Low to moderate cellularity</p>
          </list-item>
          <list-item>
            <p>Mast cells commonly found within the lesion</p>
          </list-item>
          <list-item>
            <p>Small, hyperchromatic, wavy nuclei, resembling &#x0201c;diving dolphins,&#x0201d; sometimes with nuclear enlargement and smudgy chromatin</p>
          </list-item>
          <list-item>
            <p>Nuclei may also be described as &#x0201c;buckled&#x0201d; or &#x0201c;comma-shaped.&#x0201d;</p>
          </list-item>
          <list-item>
            <p>Rarely, may encounter multinucleated giant cells</p>
          </list-item>
          <list-item>
            <p>Absent to minimal mitoses</p>
          </list-item>
          <list-item>
            <p>May also occur within the nerve (intraneural localized neurofibroma)&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Localized Type</bold>
<xref ref-type="bibr" rid="article-25784.r2">[2]</xref>
<xref ref-type="bibr" rid="article-25784.r7">[7]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Well circumscribed lesion in the dermis or subcutaneous tissue&#x000a0;
<list list-type="bullet"><list-item><p>Dermal lesions typically unencapsulated with a "grenz zone" of uninvolved dermis between lesion and epidermis</p></list-item><list-item><p>Subcutaneous lesions often have a true capsule</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Diffuse Type</bold>
<xref ref-type="bibr" rid="article-25784.r9">[9]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Poorly defined, expansile proliferation around adnexal structures, extending into the subcutaneous tissue and infiltrating adipose</p>
          </list-item>
          <list-item>
            <p>May entrap nerves or be intraneural (intraneural diffuse neurofibroma)</p>
          </list-item>
          <list-item>
            <p>Characteristic pseudomeissnerian corpuscles, comprised of fibrillary and whorled Schwann cells</p>
          </list-item>
        </list>
        <p><bold>Plexiform Type</bold><xref ref-type="bibr" rid="article-25784.r10">[10]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Multiple intertwined hypertrophic nerve fascicles&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Serpentine pattern with multiple nodules</p>
          </list-item>
          <list-item>
            <p>May have predominantly myxoid or edematous background with thick collagen fibers</p>
          </list-item>
          <list-item>
            <p>May have atypia (nuclear enlargement, hyperchromasia) related to the degenerative change</p>
          </list-item>
        </list>
        <p>
<bold>Variants Most Commonly Associated With Localized Type And Less Commonly Diffuse Type Neurofibromas</bold>
<xref ref-type="bibr" rid="article-25784.r11">[11]</xref>
<xref ref-type="bibr" rid="article-25784.r12">[12]</xref>
<xref ref-type="bibr" rid="article-25784.r13">[13]</xref>
<xref ref-type="bibr" rid="article-25784.r14">[14]</xref>
<xref ref-type="bibr" rid="article-25784.r15">[15]</xref>
<xref ref-type="bibr" rid="article-25784.r16">[16]</xref>
<xref ref-type="bibr" rid="article-25784.r17">[17]</xref>
<xref ref-type="bibr" rid="article-25784.r18">[18]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cellular: Increased cellularity, with or without atypia, no significant increase in mitotic activity</p>
          </list-item>
          <list-item>
            <p>Pigmented: Histologically and immunohistochemically shows melanin production</p>
          </list-item>
          <list-item>
            <p>Atypical/Bizarre: Hyperchromatic, pleomorphic, atypical nuclei with degenerative change, arranged in a distinct lamellar pattern</p>
          </list-item>
          <list-item>
            <p>Epithelioid: Cohesive nests of epithelioid tumor cells</p>
          </list-item>
          <list-item>
            <p>Granular cell: Contains granular cells, eosinophilic and similar in appearance to those comprising granular cell tumors</p>
          </list-item>
          <list-item>
            <p>Lipomatous: Diffusely scattered adipocytes, intrinsic to the tumor</p>
          </list-item>
          <list-item>
            <p>Dendritic cell: Dendritic cell morphology with pseudorosettes</p>
          </list-item>
          <list-item>
            <p>Hybrid neurofibroma/schwannoma: Nodules resembling schwannoma within a typical neurofibroma</p>
          </list-item>
        </list>
        <p>
<bold>Immunohistochemical Evaluation</bold>
<xref ref-type="bibr" rid="article-25784.r8">[8]</xref>
<xref ref-type="bibr" rid="article-25784.r13">[13]</xref>
<xref ref-type="bibr" rid="article-25784.r19">[19]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>S100 (+) in Schwann cells (approximately 50% of tumor cells)</p>
          </list-item>
          <list-item>
            <p>CD34 (+) in spindled fibroblasts with distinct &#x0201c;fingerprint&#x0201d; immunopositivity.
<list list-type="bullet"><list-item><p>The &#x0201c;fingerprint&#x0201d; is due to positive staining between whorled collagen bundles, resembling a human fingerprint - this &#x0201c;fingerprint,&#x0201d; if present in greater than 60% of the lesion, is useful in diagnosing neurofibroma and distinguishing neurofibroma from early desmoplastic melanoma</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>EMA (+) in occasional perineural cells</p>
          </list-item>
          <list-item>
            <p>Myelin basic protein (+)</p>
          </list-item>
          <list-item>
            <p>Neurofilament protein (+) in intratumoral axons</p>
          </list-item>
          <list-item>
            <p>Acid mucopolysaccharides (+) in mucinous stroma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25784.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with neurofibromas are often asymptomatic; however, irritation, mild pruritus, pain, or paresthesia, can occur. The presentation may vary by type of neurofibroma, but the most common chief complaint is cosmetic appearance.<xref ref-type="bibr" rid="article-25784.r20">[20]</xref></p>
        <p>Localized lesions commonly present as a painless skin-colored or violaceous papule, nodule, or subcutaneous mass. Solitary lesions are typically less than 2 cm and have a characteristic &#x0201c;buttonhole sign,&#x0201d; where on palpation, the lesion retracts into the subcutis and reappears on the release of pressure. Localized neurofibromas can occur anywhere on the body, with a predilection for the trunk, head/neck, and extremities.<xref ref-type="bibr" rid="article-25784.r21">[21]</xref>&#x000a0;Lesions are often thought to be nevi or acrochordons clinically.</p>
        <p>Diffuse neurofibromas most commonly present on the head/neck as ill-defined, indurated plaques with thickened skin. Mild numbness or tingling may occur if the lesion is large.<xref ref-type="bibr" rid="article-25784.r22">[22]</xref></p>
        <p>Plexiform neurofibromas most commonly occur on the head/neck, trunk, and extremities. They surround multiple nerve fascicles and can grow to be large. If superficial, they commonly present as a skin-colored or hyperpigmented nodular swelling. Deeper lesions arising from spinal nerve roots may become highly irregular and tortuous. Deep lesions may present with pain, numbness, paresthesias, mass effect, and sequelae of spinal nerve compression.<xref ref-type="bibr" rid="article-25784.r21">[21]</xref></p>
      </sec>
      <sec id="article-25784.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of solitary superficial lesions is often by physical exam and/or excisional biopsy with microscopic examination. Larger lesions require biopsy and/or additional imaging by CT/MRI to assess the extent of involvement and plan for surgical excision.<xref ref-type="bibr" rid="article-25784.r23">[23]</xref><xref ref-type="bibr" rid="article-25784.r24">[24]</xref></p>
      </sec>
      <sec id="article-25784.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>For most cases, complete surgical excision is the preferred treatment, with local recurrence extremely rare. There are currently no alternative therapies for cutaneous neurofibromas.<xref ref-type="bibr" rid="article-25784.r25">[25]</xref></p>
        <p>In rare cases of diffuse or plexiform neurofibromas where complete surgical excision is not possible, lesions are often totally resected for cosmetic or symptomatic relief. These patients require monitoring to watch for rapid growth or recurrence at the discretion of the clinical providers. Interferon-alpha has been studied as an adjunct therapy for plexiform neurofibromas, with variable results.<xref ref-type="bibr" rid="article-25784.r26">[26]</xref><xref ref-type="bibr" rid="article-25784.r21">[21]</xref></p>
      </sec>
      <sec id="article-25784.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Malignant peripheral nerve sheath tumor: An aggressive neurogenic neoplasm arising from peripheral nerve or pre-existing nerve sheath tumor, including neurofibromas. Approximately 50% of cases are associated with NF1. A history of rapid growth in a prior stable neurofibroma is suspicious.&#x000a0; Histologically there may be areas of admixed neurofibroma. The malignant portion will show increased cellularity, mitoses, and necrosis. Immunohistochemistry: S100 focally positive in approximately 50% of tumors.<xref ref-type="bibr" rid="article-25784.r7">[7]</xref><xref ref-type="bibr" rid="article-25784.r27">[27]</xref>&#x000a0;Epithelioid MPNST can be negative for INI-1, about 30% of the time.</p>
        <p>Schwannoma: A benign peripheral nerve sheath tumor comprised predominantly of Schwann cells. Associated with somatic and germline mutations in NF2. Histologically often more cellular, circumscribed, with Verocay bodies and Antoni A and B areas. Immunohistochemistry: Diffuse, uniform staining with S100.<xref ref-type="bibr" rid="article-25784.r28">[28]</xref></p>
        <p>Perineuroma: A rare, benign mesenchymal tumor comprised of perineural cells. No definitive association with neurofibromatosis. Immunohistochemistry: EMA(+), Claudin-1(+), GLUT1(+) S100(-), CD34(+/-).<xref ref-type="bibr" rid="article-25784.r29">[29]</xref></p>
        <p>Dermatofibroma: A benign proliferation of fibroblasts and histiocytes within the dermis. Often presents as an indurated papule. Immunohistochemistry: FXIIIA(+), CD163(+), CD68(+), CD34(-).<xref ref-type="bibr" rid="article-25784.r30">[30]</xref></p>
        <p>Dermatofibrosarcoma protuberans: A low-grade fibroblastic sarcoma affecting the dermis and subcutis, with COL1A1-PDGFB gene fusion. This lesion is locally aggressive with a high rate of recurrence (50%) and increased risk of progression and metastasis.&#x000a0;Immunohistochemistry: Diffuse CD34(+), S100(-), FXIIIA(-).<xref ref-type="bibr" rid="article-25784.r30">[30]</xref></p>
        <p>Superficial leiomyoma: A benign dermal smooth muscle neoplasm, often arising from arrector pili (pilo-leiomyoma).&#x000a0;Immunohistochemistry: SMA(+), MSA(+), Desmin (+).<xref ref-type="bibr" rid="article-25784.r31">[31]</xref></p>
        <p>Neurotized melanocytic nevus: A benign nevus with melanocytic nests and loose neurotized stroma.&#x000a0;Immunohistochemistry: Melanocytic markers(+).</p>
        <p>Ganglioneuroma: A benign tumor of neural crest origin, comprised of ganglion cells arising from nerves. Most commonly found in the posterior mediastinum and retroperitoneum. Immunohistochemistry: S100 protein stains Schwann cells and synaptophysin stains ganglion cells.&#x000a0;</p>
        <p>Plexiform fibrohistiocytic tumor: An infiltrative mesenchymal neoplasm, most commonly at the dermal-subcutaneous junction, comprised of fibroblasts and histiocytes.&#x000a0;Immunohistochemistry: SMA(+), S100 protein (-).<xref ref-type="bibr" rid="article-25784.r32">[32]</xref></p>
        <p>Desmoplastic melanoma: An invasive melanoma that often resembles a dermal scar. Frequently there is an associated melanoma in-situ. Often large at diagnosis, there can be peripheral lymphoid aggregates and cytologic atypia. Immunohistochemistry: S100 and SOX10 (+).<xref ref-type="bibr" rid="article-25784.r33">[33]</xref><xref ref-type="bibr" rid="article-25784.r34">[34]</xref></p>
      </sec>
      <sec id="article-25784.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>All types of neurofibromas are benign. Local recurrence is extremely rare complete excision of the lesion, and the risk of malignant transformation is exceedingly low; however, malignant transformation affects approximately 10% of patients with NF1.<xref ref-type="bibr" rid="article-25784.r35">[35]</xref><xref ref-type="bibr" rid="article-25784.r36">[36]</xref>&#x000a0;NF1 should be considered for any patient presenting with a plexiform neurofibroma. Plexiform types are also the most common precursor to malignant peripheral nerve sheath tumors.&#x000a0; Patients with multiple localized neurofibromas should also be candidates for further neurofibromatosis testing.<xref ref-type="bibr" rid="article-25784.r37">[37]</xref><xref ref-type="bibr" rid="article-25784.r38">[38]</xref></p>
      </sec>
      <sec id="article-25784.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The complications related to localized neurofibromas are mild and typically related to surgical excision of the lesion: pain, bleeding, scarring, and local infection. In plexiform lesions, complications arise from the inherent risks of surgery, and in rare cases, the inability to surgically remove the entire lesion. In patients with NF1 and persistent lesions, there is an increased risk of malignant transformation to malignant peripheral nerve sheath tumors.<xref ref-type="bibr" rid="article-25784.r35">[35]</xref><xref ref-type="bibr" rid="article-25784.r36">[36]</xref></p>
      </sec>
      <sec id="article-25784.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>There are no definitive risk factors for sporadic neurofibromas that develop in the absence of NF1. In the setting of multiple localized, diffuse, or plexiform neurofibromas, caf&#x000e9; au lait macules, intertriginous freckling, optic glioma, Lisch nodules, or skeletal dysplasias, neurofibromatosis should also merit diagnostic consideration.<xref ref-type="bibr" rid="article-25784.r39">[39]</xref><xref ref-type="bibr" rid="article-25784.r38">[38]</xref></p>
      </sec>
      <sec id="article-25784.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Appropriate diagnosis and treatment of neurofibromas depend on the collaborative efforts of an interprofessional healthcare team. It is crucial for the clinician to communicate history and physical exam findings to the pathologist, and for the pathologist to communicate diagnosis and&#x000a0;pertinent details to the clinician, primary care provider, and nurse practitioner, and nursing staff. An accurate history and physical, diagnosis, and interprofessional communication ensure the best outcome for the patient.<xref ref-type="bibr" rid="article-25784.r3">[3]</xref>&#x000a0;As plexiform neurofibroma is associated with NF1, care should be taken to communicate that fact to clinicians if rendering this diagnosis. Similarly, it is best to not render this diagnosis lightly without an appropriate clinical and gross description of the lesion. Dermatology and plastic surgery nurses assist with surgery, arranging for follow up, and educating patients and their families. [Level 5]</p>
      </sec>
      <sec id="article-25784.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25784&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25784">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nerve-health/neurofibroma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25784">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25784/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25784">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25784.s16">
        <fig id="article-25784.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Neurofibroma, H&#x00026;E stain, 10x magnification. Contributed by Lynn Messersmith, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NF2__1x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25784.s17">
        <fig id="article-25784.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Neurofibroma, H&#x00026;E stain, 40x magnification. Contributed by Lynn Messersmith, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NF3__4x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25784.s18">
        <fig id="article-25784.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Neurofibroma, H&#x00026;E stain, 100X magnification. Contributed by Lynn Messersmith, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NF4__10x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25784.s19">
        <fig id="article-25784.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Neurofibroma, H&#x00026;E stain, 200X magnification. Contributed by Lynn Messersmith, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NF4__20x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25784.s20">
        <fig id="article-25784.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Neurofibromatosis Contributed by S Verma, MBBS, DVD, FRCP, FAAD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Neurofibromatosis__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25784.s21">
        <title>References</title>
        <ref id="article-25784.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferner</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>O'Doherty</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Neurofibroma and schwannoma.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>679</fpage>
            <page-range>679-84</page-range>
            <pub-id pub-id-type="pmid">12447105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lassmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jurecka</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lassmann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gebhart</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Matras</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Watzek</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography.</article-title>
            <source>Virchows Arch A Pathol Anat Histol</source>
            <year>1977</year>
            <month>Sep</month>
            <day>28</day>
            <volume>375</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-210</page-range>
            <pub-id pub-id-type="pmid">143775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skovronsky</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Oberholtzer</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Pathologic classification of peripheral nerve tumors.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-66</page-range>
            <pub-id pub-id-type="pmid">15177315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hern&#x000e1;ndez-Mart&#x000ed;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duat-Rodr&#x000ed;guez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An Update on Neurofibromatosis Type 1: Not Just Caf&#x000e9;-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>107</volume>
            <issue>6</issue>
            <fpage>454</fpage>
            <page-range>454-64</page-range>
            <pub-id pub-id-type="pmid">26979265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferner</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Neurofibromatosis type 1 (NF1): diagnosis and management.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>115</volume>
            <fpage>939</fpage>
            <page-range>939-55</page-range>
            <pub-id pub-id-type="pmid">23931823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tucker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Riccardi</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sutcliffe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vielkind</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wolkenstein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.</article-title>
            <source>J Neurosci Res</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>89</volume>
            <issue>9</issue>
            <fpage>1451</fpage>
            <page-range>1451-60</page-range>
            <pub-id pub-id-type="pmid">21674567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodruff</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.</article-title>
            <source>Am J Med Genet</source>
            <year>1999</year>
            <month>Mar</month>
            <day>26</day>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-30</page-range>
            <pub-id pub-id-type="pmid">10469433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Amico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vecchio</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Caltabiano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Castaing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kacerovska</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kazakov</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Michal</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Multinucleated floret-like giant cells in sporadic and NF1-associated neurofibromas: a clinicopathologic study of 94 cases.</article-title>
            <source>Virchows Arch</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>456</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-6</page-range>
            <pub-id pub-id-type="pmid">19937344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiurba</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Eng</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Urich</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The structure of pseudomeissnerian corpuscles. An immunohistochemical study.</article-title>
            <source>Acta Neuropathol</source>
            <year>1984</year>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>174</fpage>
            <page-range>174-6</page-range>
            <pub-id pub-id-type="pmid">6428156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tchernev</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chokoeva</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Bakardzhiev</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wollina</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tana</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Plexiform Neurofibroma: A Case Report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>95</volume>
            <issue>6</issue>
            <fpage>e2663</fpage>
            <pub-id pub-id-type="pmid">26871793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Medeiros</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>12</issue>
            <fpage>1443</fpage>
            <page-range>1443-9</page-range>
            <pub-id pub-id-type="pmid">9414187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Motoi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Motoi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fukayama</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor.</article-title>
            <source>Hum Pathol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>871</fpage>
            <page-range>871-7</page-range>
            <pub-id pub-id-type="pmid">16112003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jokinen</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Argenyi</surname>
                <given-names>ZB</given-names>
              </name>
            </person-group>
            <article-title>Atypical neurofibroma of the skin and subcutaneous tissue: clinicopathologic analysis of 11 cases.</article-title>
            <source>J Cutan Pathol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">19469864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laskin</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Fetsch</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Lasota</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miettinen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Benign epithelioid peripheral nerve sheath tumors of the soft tissues: clinicopathologic spectrum of 33 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-51</page-range>
            <pub-id pub-id-type="pmid">15613855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finkel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Granular cell variant of neurofibromatosis: ultrastructure of benign and malignant tumors.</article-title>
            <source>Hum Pathol</source>
            <year>1982</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>959</fpage>
            <page-range>959-63</page-range>
            <pub-id pub-id-type="pmid">6290371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Val-Bernal</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Vela</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous lipomatous neurofibroma: characterization and frequency.</article-title>
            <source>J Cutan Pathol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>274</fpage>
            <page-range>274-9</page-range>
            <pub-id pub-id-type="pmid">15769276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fanburg-Smith</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mentzel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kutzner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Requena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zamecnik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miettinen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dendritic cell neurofibroma with pseudorosettes: a report of 18 cases of a distinct and hitherto unrecognized neurofibroma variant.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2001</year>
            <month>May</month>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>587</fpage>
            <page-range>587-94</page-range>
            <pub-id pub-id-type="pmid">11342769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wesemann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hagel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schittenhelm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tatagiba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jeibmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bohring</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mautner</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Paulus</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2012</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>702</fpage>
            <page-range>702-9</page-range>
            <pub-id pub-id-type="pmid">22446939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>McCalmont</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint.</article-title>
            <source>J Cutan Pathol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>625</fpage>
            <page-range>625-30</page-range>
            <pub-id pub-id-type="pmid">21457155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolkenstein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zeller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Revuz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ecosse</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lepl&#x000e8;ge</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases.</article-title>
            <source>Arch Dermatol</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>137</volume>
            <issue>11</issue>
            <fpage>1421</fpage>
            <page-range>1421-5</page-range>
            <pub-id pub-id-type="pmid">11708944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staser</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Clapp</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.</article-title>
            <source>Annu Rev Pathol</source>
            <year>2012</year>
            <volume>7</volume>
            <fpage>469</fpage>
            <page-range>469-95</page-range>
            <pub-id pub-id-type="pmid">22077553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Gopal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Talwar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramesh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diffuse neurofibroma of the scalp presenting as circumscribed alopecic patch.</article-title>
            <source>Int J Trichology</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-2</page-range>
            <pub-id pub-id-type="pmid">21188030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raffensperger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Plexiform neurofibromas in childhood.</article-title>
            <source>J Pediatr Surg</source>
            <year>1972</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-51</page-range>
            <pub-id pub-id-type="pmid">4623404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serletis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Parkin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bouffet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shroff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Drake</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rutka</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Massive plexiform neurofibromas in childhood: natural history and management issues.</article-title>
            <source>J Neurosurg</source>
            <year>2007</year>
            <month>May</month>
            <volume>106</volume>
            <issue>5 Suppl</issue>
            <fpage>363</fpage>
            <page-range>363-7</page-range>
            <pub-id pub-id-type="pmid">17566202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allaway</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Gosline</surname>
                <given-names>SJC</given-names>
              </name>
              <name>
                <surname>La Rosa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guinney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>LQ</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous neurofibromas in the genomics era: current understanding and open questions.</article-title>
            <source>Br J Cancer</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>118</volume>
            <issue>12</issue>
            <fpage>1539</fpage>
            <page-range>1539-1548</page-range>
            <pub-id pub-id-type="pmid">29695767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kebudi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cakir</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Gorgun</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Interferon-&#x003b1; for unresectable progressive and symptomatic plexiform neurofibromas.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>e115</fpage>
            <page-range>e115-7</page-range>
            <pub-id pub-id-type="pmid">23042022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hornick</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Limited biopsies of soft tissue tumors: the contemporary role of immunohistochemistry and molecular diagnostics.</article-title>
            <source>Mod Pathol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>Suppl 1</issue>
            <fpage>27</fpage>
            <page-range>27-37</page-range>
            <pub-id pub-id-type="pmid">30600320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jo</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>CDM</given-names>
              </name>
            </person-group>
            <article-title>SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>8</issue>
            <fpage>1013</fpage>
            <page-range>1013-1022</page-range>
            <pub-id pub-id-type="pmid">28368924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zelger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weinlich</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zelger</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Perineuroma. A frequently unrecognized entity with emphasis on a plexiform variant.</article-title>
            <source>Adv Clin Path</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-33</page-range>
            <pub-id pub-id-type="pmid">10936896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadullaho&#x0011f;lu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dere</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Atasever</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>&#x000d6;ztop</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Karaaslan</surname>
                <given-names>&#x000d6;</given-names>
              </name>
            </person-group>
            <article-title>The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.</article-title>
            <source>Turk Patoloji Derg</source>
            <year>2017</year>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>223</fpage>
            <page-range>223-227</page-range>
            <pub-id pub-id-type="pmid">28832078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magro</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Differential Diagnosis of Benign Spindle Cell Lesions.</article-title>
            <source>Surg Pathol Clin</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-121</page-range>
            <pub-id pub-id-type="pmid">29413661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Remstein</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Arndt</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>662</fpage>
            <page-range>662-70</page-range>
            <pub-id pub-id-type="pmid">10366148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrams</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Tait</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eisenberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van Echo</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Olver</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Aisner</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Phase II trial of N-methylformamide in advanced renal cancer.</article-title>
            <source>Am J Clin Oncol</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-2</page-range>
            <pub-id pub-id-type="pmid">2912020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ochoa</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Desmoplastic melanoma: a brief review and the efficacy of immunotherapy.</article-title>
            <source>Expert Rev Anticancer Ther</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-207</page-range>
            <pub-id pub-id-type="pmid">30686076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gregorian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dry</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Nghiemphu</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Ao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mellinghoff</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Mischel</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parada</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Sofroniew</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Eilber</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>PTEN dosage is essential for neurofibroma development and malignant transformation.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2009</year>
            <month>Nov</month>
            <day>17</day>
            <volume>106</volume>
            <issue>46</issue>
            <fpage>19479</fpage>
            <page-range>19479-84</page-range>
            <pub-id pub-id-type="pmid">19846776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spurlock</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kiehl</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Guha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Upadhyaya</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.</article-title>
            <source>J Cancer Res Clin Oncol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>136</volume>
            <issue>12</issue>
            <fpage>1869</fpage>
            <page-range>1869-80</page-range>
            <pub-id pub-id-type="pmid">20229272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gesundheit</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Parkin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baruchel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Senger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kapelushnik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Klement</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>548</fpage>
            <page-range>548-53</page-range>
            <pub-id pub-id-type="pmid">20686424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaefer</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>1234</fpage>
            <page-range>1234-41</page-range>
            <pub-id pub-id-type="pmid">25929351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25784.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garozzo</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience.</article-title>
            <source>Neurol India</source>
            <year>2019</year>
            <season>Jan-Feb</season>
            <volume>67</volume>
            <issue>Supplement</issue>
            <fpage>S38</fpage>
            <page-range>S38-S44</page-range>
            <pub-id pub-id-type="pmid">30688231</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
